Variant report
Variant | esv2462705 |
---|---|
Chromosome Location | chr9:16389073-16390515 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs573251268 | chr9:16389085-16389086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs369588292 | chr9:16389094-16389095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs10756752 | chr9:16389209-16389210 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs573957679 | chr9:16389233-16389234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139923033 | chr9:16389238-16389239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562934977 | chr9:16389258-16389259 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs530732462 | chr9:16389325-16389326 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs545973034 | chr9:16389326-16389327 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs188537966 | chr9:16389390-16389391 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564270044 | chr9:16389397-16389398 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377379929 | chr9:16389403-16389404 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs139108406 | chr9:16389407-16389408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs201720803 | chr9:16389408-16389409 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs201483095 | chr9:16389609-16389610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs199715950 | chr9:16389623-16389624 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs151025994 | chr9:16389752-16389753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs77929184 | chr9:16389768-16389769 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs567990255 | chr9:16389780-16389781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs528848728 | chr9:16389786-16389787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34205747 | chr9:16389820-16389821 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs375922319 | chr9:16389826-16389827 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs376172580 | chr9:16389851-16389852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs539146363 | chr9:16389869-16389870 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs114958771 | chr9:16389883-16389884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs149791832 | chr9:16389891-16389892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs534254103 | chr9:16389902-16389903 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111335953 | chr9:16389903-16389904 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540928624 | chr9:16389906-16389907 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs573966195 | chr9:16389939-16389940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs36014733 | chr9:16389952-16389953 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs145581391 | chr9:16389970-16389971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs143201344 | chr9:16389987-16389988 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs78642394 | chr9:16390005-16390006 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs76587767 | chr9:16390007-16390008 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs185062676 | chr9:16390008-16390009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75174246 | chr9:16390038-16390039 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540177420 | chr9:16390064-16390065 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562867662 | chr9:16390072-16390073 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs374693354 | chr9:16390080-16390081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs528887022 | chr9:16390091-16390092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148873188 | chr9:16390096-16390097 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144171721 | chr9:16390127-16390128 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs188325301 | chr9:16390143-16390144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551041163 | chr9:16390155-16390156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs114351921 | chr9:16390175-16390176 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs192662286 | chr9:16390208-16390209 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs12380533 | chr9:16390214-16390215 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs555794593 | chr9:16390222-16390223 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs567901636 | chr9:16390234-16390235 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538153958 | chr9:16390286-16390287 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Lung cancer | 18438408 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Autism | 22495311 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pilocytic astrocytoma | 18670637 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Melanoma | 22183965 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Glycine encephalopathy | 21572526 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
Breast cancer | 21611746 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:16388800-16393400 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr9:16389000-16390200 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr9:16390200-16390400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr9:16390200-16390600 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
5 | chr9:16390400-16393800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |